Finding Value for Protons: The Case of Prostate Cancer?
Where this comes from
- Record sourced from PubMed, PMID 29735189.
- Also identified by DOI 10.1016/j.semradonc.2017.11.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The standard radiotherapy treatment for prostate cancer is intensity-modulated radiotherapy (IMRT). An alternative option is proton beam therapy (PBT). PBT is a safe and effective treatment, but does it add value over IMRT? We explore this controversial question by examining the available dosimetric and clinical evidence.
Medical subject headings
- Prostatic Neoplasms
- Proton Therapy